相关实验视频
Updated: Sep 13, 2025

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.3K
GLP-1激动剂:在疼痛治疗和成中改变了游戏规则
Sahil Bade1, Mark Friedrich B Hurdle2, Sohail Bade1
1Department of Family Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
Pain management
|July 29, 2025
概括
类似葡萄糖-1受体激动剂 (GLP-1RAs) 显示出慢性疼痛缓解和成治疗的潜力. 需要进一步的研究来证实其除了体重管理之外的有效性和安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
- 内分泌学 在内分泌学.
背景情况:
- 慢性疼痛是一个重大的医疗保健挑战,目前的治疗方法通常与不良影响和依赖有关.
- 最初用于代谢障碍的葡萄糖类-1受体激活剂 (GLP-1RAs),正在成为治疗疼痛和物质使用障碍的潜在治疗剂.
研究的目的:
- 审查GLP-1RAs在疼痛管理中的新兴作用,包括它们对炎症,氧化应激和神经通路的影响.
- 探索GLP-1RAs在治疗物质使用障碍,特别是酒精成方面的潜力.
主要方法:
- 从2000年1月到2025年2月,在PubMed和Embase (Ovid) 进行了全面的文献搜索.
- 确定并分析了研究GLP-1RAs在头痛,关节炎,糖尿病神经病变和物质使用障碍的背景下进行的研究.
主要成果:
- GLP-1RAs显示出潜在的止痛特性,并可能减轻寻找药物的行为,为阿片类药物和手术提供替代品.
- 有证据表明GLP-1RAs可以减少骨关节炎的炎症和软骨退化,并促进糖尿病神经病变中的神经修复.
- 临床前研究表明GLP-1RAs在偏头痛途径中的作用,临床试验在酒精成治疗中显示出有前途.
结论:
- GLP-1RAs代表了慢性疼痛和物质使用障碍的有希望的治疗途径,可能减少对传统治疗的依赖.
- 需要进行进一步的大规模临床试验,以验证GLP-1RAs在各种疼痛条件和成中有效性,最佳剂量和长期影响.
相关概念视频
Glucagon-like Receptor Agonists
420
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
420
Analgesia and Pain Management
803
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
803
Opioid Analgesics: Synthetic and Semisynthetic Opioids
437
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
437
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Opioid Analgesics: Morphine and Other Natural Cogeners
366
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
366

